Table 3.
NGAL | MELD | MELD + NGAL | P value | MELD-Na | MELD-Na + NGAL | P value | CLIF-C ACLF | CLIF-C ACLF + NGAL | P value | |
Transplant-free survival | ||||||||||
C statistic | 0.697 | 0.686 | 0.713 | 0.04 | 0.683 | 0.708 | 0.06 | 0.663 | 0.697 | 0.04 |
Category-free NRI | 0.368 | 0.008 | 0.349 | 0.01 | 0.375 | 0.007 | ||||
IDI | 0.027 | 0.02 | 0.029 | 0.02 | 0.036 | 0.007 | ||||
Overall survival | ||||||||||
C statistic | 0.688 | 0.596 | 0.662 | 0.005 | 0.581 | 0.653 | 0.004 | 0.620 | 0.675 | 0.02 |
Category-free NRI | 0.360 | 0.01 | 0.388 | 0.008 | 0.364 | 0.01 | ||||
IDI | 0.052 | 0.007 | 0.055 | 0.006 | 0.056 | 0.006 |
ACLF, acute-on-chronic liver failure; CLIF-C ACLF, Chronic Liver Failure Consortium Acute-on-Chronic Liver Failure score; IDI, integrated discrimination increment; MELD, Model for End-Stage Liver Disease; NGAL, neutrophil gelatinase-associated lipocalin; NRI, net reclassification index.